Alan Shaw

President, CEO and Co-Founder, Calysta

PhD in Chemistry, University of Durham. Formerly: in various scientific, business development and sales and marketing posts in the chemicals industry; Managing Director and Member of the Board, Chirotech Technology (fine chemicals division of ChiroScience Group); Chief Operating Officer, Archimica Fine Chemicals (fine chemicals division of BTP); until 2001, Head, New Business Development and Managing Director, Lancaster Synthesis Group, Clariant Life Science Molecules (Clariant's Life Science and Electronics division); also, Member, Clariant Life Science Molecules Executive Management Team. Since September 2001, Maxygen.

About us

Engage with us

  • Sign in
  • Partner with us
  • Become a member
  • Sign up for our press releases
  • Subscribe to our newsletters
  • Contact us

Quick links

Language editions

Privacy Policy & Terms of Service

Sitemap

© 2025 World Economic Forum